These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19482098)

  • 1. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
    Forner A; Reig M; Bruix J
    Gastroenterology; 2009 Jul; 137(1):26-9. PubMed ID: 19482098
    [No Abstract]   [Full Text] [Related]  

  • 2. Some patients with HCC haven't abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels.
    Bertino G; Ardiri AM; Santonocito MM; Boemi PM
    Panminerva Med; 2009 Jun; 51(2):133-4. PubMed ID: 19776714
    [No Abstract]   [Full Text] [Related]  

  • 3. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How many patients with HCC have normal des-gamma-carboxy prothrombin and alpha-fetoprotein levels?
    Castelli A
    Panminerva Med; 2009 Sep; 51(3):188. PubMed ID: 19859054
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 8. Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
    Koh T; Taniguchi H; Katoh H; Kunishima S; Yamaguchi A; Yamagishi H
    Hepatogastroenterology; 2002; 49(48):1615-8. PubMed ID: 12397748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
    Ishida H; Matsuo S; Inoue Y
    Rinsho Byori; 2010 Nov; 58(11):1065-72. PubMed ID: 21229703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical significance of PIVKA-II in hepatocellular carcinoma: a comparative study with alpha-fetoprotein: preliminary report].
    Sakon M; Monden M; Gotoh M; Kanai T; Umeshita K; Endoh W; Mori T
    Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):1129. PubMed ID: 2477681
    [No Abstract]   [Full Text] [Related]  

  • 11. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers.
    Iizuka N; Oka M; Sakaida I; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Yamashita S; Okita K; Sakata K; Karino Y; Toyota J; Ando E; Ide T; Sata M; Tsunedomi R; Tsutsui M; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Fujita Y; Hamamoto Y
    Clin Chim Acta; 2011 Jan; 412(1-2):152-8. PubMed ID: 20883676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
    Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS
    Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
    Aoyagi Y; Yanagi M; Asakura H
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
    Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
    Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.